#3 Boston Scientific Corporation (NYSE:BSX)
– Shares Owned by MFP Investors (as of September 30): 1.98 Million
– Value of Holding (as of September 30): $32.5 Million
Similar to what happened with Teva Pharmaceutical Industries, MFP Investors didn’t made any changes to its stake in Boston Scientific Corporation (NYSE:BSX) during the third quarter. Owing largely to the boisterous rally shares of Boston Scientific Corporation (NYSE:BSX) enjoyed during the first quarter of the year, they are currently trading up by 38.34% year-to-date. 37 of the over 700 hedge funds that we cover reported having a stake in the company as of the end of September, with them having an aggregate value of almost $1.48 billion. On November 13, analysts at Evercore ISI reiterated their ‘Buy’ rating and $20 price target on the stock, which represents a potential upside of around 10%. With ownership of over 24 million shares of the company, Samuel Isaly‘s Orbimed Advisors was its largest shareholder at the end of September among the funds tracked by Insider Monkey.
#2 Dolby Laboratories, Inc. (NYSE:DLB)
– Shares Owned by MFP Investors (as of September 30): 1.02 Million
– Value of Holding (as of September 30): $33.4 Million
MFP Investors made full use of the 17.6% decline that shares of Dolby Laboratories, Inc. (NYSE:DLB) suffered during the third quarter by increasing its stake in the company by 45% during that period. Other hedge funds also largely shared the same sentiment towards the stock during that period, because even though its ownership among the hedge funds tracked by us remained the same at 21, the aggregate value of hedge funds’ holdings in it climbed to $162.44 million by the end of September from $153.44 million at the end of June, despite the big share price decline. Dolby Laboratories, Inc. came out with mixed results for its fourth quarter of fiscal year 2015. While the Street had estimated that it would declare EPS of $0.31 on revenue of $235.76 million, it declared EPS of $0.41 on revenue of $229.50 million. Peter S. Park‘s Park West Asset Management was one of the hedge funds that initiated a stake in the company during the third quarter.
#1 Intel Corporation (NASDAQ:INTC)
– Shares Owned by MFP Investors (as of September 30): 1.85 Million
– Value of Holding (as of September 30): $55.76 Million
Finally, not only did MFP Investors not make any changes to its stake in Intel Corporation (NASDAQ:INTC) during the third quarter, but the shares of the company also remained flat during that period, ensuring that it continued to remain MFP Investors’ top stock pick at the end of September. After declining gradually since the start of the year, shares of Intel Corporation saw a rebound in September and October which has helped it narrow its year-to-date losses down to 5%. Most analysts that cover the company remain skeptical about its growth and the same sentiment seems to be shared by hedge funds. The number of hedge funds covered by Insider Monkey that disclosed a stake in Intel Corporation (NASDAQ:INTC) came down to 45 at the end of September from 48 at the end of June. Moreover, the aggregate value of hedge funds’ holdings in the stock also dropped to $3.67 billion from $4.21 billion. Andrew Feldstein and Stephen Siderow‘s Blue Mountain Capital reduced its stake in the company by 44% to 17 million shares during the third quarter.
Disclosure: None
